1. Scrip
  2. >>COVID-19

CVS CEO Merlo On COVID-19 Vaccination: "Think Of It Like Booking A Travel Ticket"

 
• By Jessica Merrill

The pharmacy will be ready to begin COVID-19 vaccinations 48 hours after receiving the vaccine, Merlo said, outlining plans for a mass vaccination effort that will include online appointments.

Close up of a Doctor making a vaccination in the shoulder of patient,
CVS is preparing a mass COVID-19 vaccination plan • Source: Shutterstock

CVS Health Corp. CEO Larry Merlo outlined initial plans for a mass COVID-19 vaccination effort at the Forbes virtual Healthcare Summit on 2 December, including how the pharmacy plans to meet the thermal cold-chain demands required for Pfizer’s COVID-19 vaccine and book vaccination appointments for the general public.

"Our goal is to be ready to go 48 hours after we take receipt of the vaccine," Merlo said

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from COVID-19

More from Scrip

Finance Watch: Deerfield Closes $600m-Plus VC Fund; Gates Speeds Up Health Investments

 
• By Mandy Jackson

Private Company Edition: Deerfield’s third innovations fund will back therapeutics and other opportunities, the Gates Foundation – a sometimes funder of biotech firms – will spend $200bn over the next 20 years, and NewLimit raised a $130m series B round, among other financings.

Pipeline Watch: Six Approvals And Thirteen Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pharma Left Hanging After US/UK Trade Pact

 
• By Kevin Grogan

An ‘historic economic prosperity deal’ does not include the sector.